Dr. Rajesh Rao interviews Dr. Katherine E. Talcott on her Ophthalmology Retina article "Risks of Retinal Vascular Occlusions with the Systemic Use of Tyrosine Kinase Inhibitors." They discuss the study which aimed to characterize the associations between systemic TKIs and the risks of retinal artery occlusion and retinal vein occlusion.

Jeong H, et al. Risks of Retinal Vascular Occlusions with the Systemic Use of Tyrosine Kinase Inhibitors. Ophthalmology Retina, 2026; Volume 10, Issue 7, 734-744.

The 2026–2027 BCSC Section 12: Retina and Vitreous features expanded updates on AMD and recently approved intravitreal injections and gene therapies, updated hydroxychloroquine guidance, 15 new surgical and diagnostic videos, and two interactive case studies. Order Section 12 today at www.aao.org/BCSC

AAO 2026 may be over in New Orleans, but the learning continues through March 2027. Access more than 300 expert-led sessions on your schedule, from wherever you are. Experience the discussions shaping ophthalmology alongside clinical education, posters, Subspecialty Day and Cataract Spotlight. Earn CME credits and watch sessions now. Get access today at www.aao.org/RegNow

Dr. Drew Carey speaks with Dr. Abdelrahman Elhusseiny on his study of the association between topical carbonic anhydrase inhibitor use and the development of depression and anxiety disorders in patients with glaucoma. From his Ophthalmology Science article, "Depression and Anxiety After Topical Carbonic Anhydrase Inhibitors."

Elhusseiny A, et al. Depression and Anxiety After Topical Carbonic Anhydrase Inhibitors. Ophthalmology Science, Volume 6, Issue 4.

Ophthalmology journal events at AAO 2026:

• Peer Review Masterclass: A Practical Workshop for Journal Authors and Reviewers: Become a peer reviewer for the Academy's Ophthalmology journal, the leading journal in the field, and its companion journals, Ophthalmology Retina, Ophthalmology Glaucoma, and Ophthalmology Science. Dr. Aaki Shukla and Dr. Benjamin Xu, highly experienced reviewers and authors for various journals, will lead this free interactive workshop. Sponsored by Elsevier. Saturday October 10 at 10:30am CT in the Academy Theater.
• The Year in Literature: Editor's Choice Highlights From the Ophthalmology Journal Family: Join Bennie H. Jeng MD, Editor-in-Chief of Ophthalmology, and Russell N. Van Gelder, MD, PhD, Distinguished Senior Editor of Ophthalmology, as they guide you through the picks for the most important papers published in these journals in the past year. Selected papers will be made available as open access online following the symposium to encourage further reading. October 11 at 8am CT. Location: Room 271-273. Search SYM32 in the Mobile Meeting Guide.

Dr. Edmund Tsui interviews a team of researchers from New York University Grossman School of Medicine: Galen Hu, MD, Vivek Srinivasan, PhD, and Nitish Mehta, MD. The team discusses their case study which applied ultra-high resolution visible light optical coherence tomography towards acute and chronic lacquer cracks in a patient with pathologic myopia. From their Ophthalmology Science article, "Insights on Acute and Chronic Lacquer Cracks as Imaged with Visible Light OCT."

Hu G, et al. Insights on Acute and Chronic Lacquer Cracks as Imaged with Visible Light OCT. Ophthalmology Science, 2026; Volume 6, Issue 4.

AAO 2026 is almost here! Join the international ophthalmology community October 9-12 for expert education, the latest clinical insights and the conversations shaping the future of ophthalmology.

Can't make it to New Orleans? Bring AAO 2026 to you with the virtual meeting. Access live and recorded education from wherever you are, anywhere in the world. Register at www.aao.org/RegNow

Ophthalmology journal events at AAO 2026:

• Peer Review Masterclass: A Practical Workshop for Journal Authors and Reviewers: Become a peer reviewer for the Academy's Ophthalmology journal, the leading journal in the field, and its companion journals, Ophthalmology Retina, Ophthalmology Glaucoma, and Ophthalmology Science. Dr. Aaki Shukla and Dr. Benjamin Xu, highly experienced reviewers and authors for various journals, will lead this free interactive workshop. Sponsored by Elsevier. Saturday October 10 at 10:30am CT in the Academy Theater.
• The Year in Literature: Editor's Choice Highlights From the Ophthalmology Journal Family: Join Bennie H. Jeng MD, Editor-in-Chief of Ophthalmology, and Russell N. Van Gelder, MD, PhD, Distinguished Senior Editor of Ophthalmology, as they guide you through the picks for the most important papers published in these journals in the past year. Selected papers will be made available as open access online following the symposium to encourage further reading. October 11 at 8am CT. Location: Room 271-273. Search SYM32 in the Mobile Meeting Guide.

The 2026–2027 BCSC Section 12: Retina and Vitreous features expanded updates on AMD and recently approved intravitreal injections and gene therapies, updated hydroxychloroquine guidance, 15 new surgical and diagnostic videos, and two interactive case studies. Order Section 12 today at www.aao.org/BCSC

Dr. Emily is Schehlein is joined by Dr. Clara C. Chan and medical student Andrew Mihalache to discuss their report that showed individuals with Fuchs' endothelial corneal dystrophy exhibited a higher burden of cardiometabolic disease than matched controls. From their Ophthalmology article, "Fuchs' Endothelial Corneal Dystrophy and Cardiometabolic Comorbidities."

Mihalache A, et al. Fuchs' Endothelial Corneal Dystrophy and Cardiometabolic Comorbidities. Ophthalmology, 2026; Volume 133, Issue 6, 777-779.

Ophthalmology journal events at AAO 2026:

• Peer Review Masterclass: A Practical Workshop for Journal Authors and Reviewers: Become a peer reviewer for the Academy's Ophthalmology journal, the leading journal in the field, and its companion journals, Ophthalmology Retina, Ophthalmology Glaucoma, and Ophthalmology Science. Dr. Aaki Shukla and Dr. Benjamin Xu, highly experienced reviewers and authors for various journals, will lead this free interactive workshop. Sponsored by Elsevier. Saturday October 10 at 10:30am CT in the Academy Theater.
• The Year in Literature: Editor's Choice Highlights From the Ophthalmology Journal Family: Join Bennie H. Jeng MD, Editor-in-Chief of Ophthalmology, and Russell N. Van Gelder, MD, PhD, Distinguished Senior Editor of Ophthalmology, as they guide you through the picks for the most important papers published in these journals in the past year. Selected papers will be made available as open access online following the symposium to encourage further reading. October 11 at 8am CT. Location: Room 271-273. Search SYM32 in the Mobile Meeting Guide.

Dr. Rukhsana Mirza is joined Dr. Dr. Anne Coleman. They discuss Dr. Coleman's study evaluating whether the Pooled Cohort Equations cardiovascular risk scores are associated with the future development and can predict future development of age-related macular degeneration, glaucoma, diabetic retinopathy, retinal vein occlusion, and hypertensive retinopathy. From her Ophthalmology article, "Cardiovascular Risk and Eye Health: A Cohort Study of the Pooled Cohort Equations and Ocular Disease Incidence."

Cardiovascular Risk and Eye Health: A Cohort Study of the Pooled Cohort Equations and Ocular Disease Incidence. Sun D, et al. Ophthalmology, Volume 133, Issue 5, 645-653.

The 2026–2027 BCSC Section 12: Retina and Vitreous features expanded updates on AMD and recently approved intravitreal injections and gene therapies, updated hydroxychloroquine guidance, 15 new surgical and diagnostic videos, and two interactive case studies. Order Section 12 today at www.aao.org/BCSC

Join colleagues from around the world at AAO 2026, October 9-12 in New Orleans. Experience four days of expert education, hands-on learning, the Expo, meaningful connections and the moments that make this the ophthalmology event of the year. Advance registration savings end September 9. Register now at www.aao.org/RegNow

Dr. Rukhsana Mirza interviews ophthalmology residents Drs. Rita Vought and Victoria Vought on their recent study investigating clinical characteristics that impact ischemic stroke or transient ischemic attack risk after the first retinal artery occlusion or amaurosis fugax among adults. From their Ophthalmology Retina article, "Stroke Risk after Ischemic Ocular Events: Insights from an Electronic Health Record Database."

Vought V, et al. Stroke Risk after Ischemic Ocular Events: Insights from an Electronic Health Record Database. Ophthalmology Retina, 2026. Volume 10, Issue 7, 764-773.

For more information about submitting to the Artificial Intelligence in Ophthalmology Special Collection, please visit https://www.aaojournal.org/ai-in-ophthalmology or email aaojournal@aao.org.

How does a case of viral conjunctivitis lead to a study on ophthalmic drug shortages in the United States? Dr. Emily Schehlein finds out from Dr. Ian Pitha as they discuss his Ophthalmology article "Ophthalmic Drug Shortages in the United States: Survey of the University of Utah Drug Information Service Drug Shortage Database."

Ophthalmic Drug Shortages in the United States: Survey of the University of Utah Drug Information Service Drug Shortage Database. Eakins R T, Nguyen Lowrie L, Stagg B C, et al. Ophthalmology. In press.

Early registration for the 2026 AAO Annual Meeting ends on August 5. Secure your spot at https://www.aao.org/regnow

For more information about submitting to the Artificial Intelligence in Ophthalmology Special Collection, please visit https://www.aaojournal.org/ai-in-ophthalmology or email aaojournal@aao.org.

A special episode hosted by Ophthalmology's Editor-in-Chief, Dr. Bennie Jeng. He is joined by Associate Editor Dr. Aaron Lee to announce our new special collection on Artificial Intelligence in Ophthalmology. They discuss how AI is already changing the practice of ophthalmology and medical publishing. Dr. Lee then outlines the types of articles we are looking for in our new special collection.

For more information about submitting to the Artificial Intelligence in Ophthalmology Special Collection, please visit https://www.aaojournal.org/ai-in-ophthalmology.